| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/09/2008 | CN101099865A A blocking monoclonal antibody to VLA-1 and its use for the treatment of vascular disorders |
| 01/09/2008 | CN101099745A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/09/2008 | CN100360722C Digital assay |
| 01/09/2008 | CN100360175C Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 01/09/2008 | CN100360173C Lyase treatment for p. carinii |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | US7316907 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 01/08/2008 | US7316813 Influenza vaccine composition |
| 01/08/2008 | CA2296031C Novel spiroazabicyclic heterocyclic compounds |
| 01/03/2008 | WO2005032476A3 Methods and compositions for cpg15-2 |
| 01/03/2008 | US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| 01/03/2008 | US20080004305 Intranasal Opioid Compositions |
| 01/03/2008 | US20080004278 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 01/03/2008 | US20080004250 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/03/2008 | US20080004235 Topical compositions comprising one or more of 4-thiouridine, isomaltitol and uridine |
| 01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
| 01/02/2008 | EP1695094A4 Disintegratable films for diagnostic devices |
| 01/02/2008 | EP1638492B1 Preoperative treatment of post operative pain |
| 01/02/2008 | EP1631267B1 Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites |
| 01/02/2008 | EP1587924B1 Methods for site-directed mutagenesis and targeted randomization |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | EP0610335B1 Methods for designing recombitope peptides |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN100358897C 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314939 Compositions and methods for inhibiting TGF-β |
| 01/01/2008 | US7314880 Cardioprotective delta opioid receptor agonists and methods of using same |
| 01/01/2008 | US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide |
| 01/01/2008 | US7314460 Extracorporeal pathogen reduction system |
| 12/27/2007 | WO2005044200A3 Methods and compositions for treating mcp-1 related pathologies |
| 12/27/2007 | US20070299121 administering sublingually to a horse a semisolid transmucosal gel containing detomidine, hydroxypropyl cellulose, sodium lauryl sulfate, propylene glycol and water for providing sedation and analgesia; rapid onset of action, low irritation potential in the oral mucosa |
| 12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
| 12/27/2007 | US20070298125 Medical Solution, A Method For Producing Said Medical Solution And Use Thereof |
| 12/27/2007 | US20070298120 Photoreactive Compound Specifically Binding to Calcium Binding Proteins |
| 12/27/2007 | US20070298092 Compositions for Delivery of Drug Combinations |
| 12/27/2007 | US20070297982 Preparation And Composition Of Inter-Alpha Inhibitor Proteins From Human Plasma For Therapeutic Use |
| 12/26/2007 | EP1870109A1 Improved combined vaccine against mycoplasma hyopneumoniae and porcine viruses |
| 12/26/2007 | EP1592437A4 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 12/26/2007 | CN101094681A Dialysates and methods and systems related thereto |
| 12/26/2007 | CN101094650A Compositions and methods for reducing scar tissue formation |
| 12/26/2007 | CN101092609A Vaccine against mumps containing a JERYL-LYNN virus strain |
| 12/26/2007 | CN101091792A Multi-dose erythropoietin formulations |
| 12/26/2007 | CN100356978C Novel exendin agonist formulations and methods administration thereof |
| 12/26/2007 | CN100356935C Formulations useful in the treatment of male and female impotence |
| 12/26/2007 | CN100356903C Method and agents for permanently shaping keratin fibres |
| 12/25/2007 | US7312242 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 12/25/2007 | US7312241 Diphenylethylene compounds and uses thereof |
| 12/25/2007 | US7312228 Cytotoxic indeno and isoindoloisoquinolones |
| 12/25/2007 | US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis |
| 12/25/2007 | US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/25/2007 | US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 12/25/2007 | US7311902 Conjugates comprising human IL-18 and substitution mutants thereof |
| 12/21/2007 | WO2005023193A3 Methods of treating endometriosis |
| 12/21/2007 | WO2004071405A3 Lactate dehydrogenase: a target and reagent for diabetes therapy |
| 12/21/2007 | WO2004069178A3 Anti-inflammatory activity from lactic acid bacteria |
| 12/20/2007 | US20070293542 Selective Cox-2 Inhibitors |
| 12/20/2007 | US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease |
| 12/20/2007 | US20070293500 Quinazoline derivatives as medicaments |
| 12/20/2007 | US20070292527 Composition for the cosmetic treatment of age-related dermatological symptoms |
| 12/20/2007 | US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer |
| 12/20/2007 | US20070292456 Formulations Containing an Immune Response Modifier |
| 12/19/2007 | EP1654045A4 Building element for constructing a modular substructure |
| 12/19/2007 | EP1654003B1 Preventative effects of morinda citrifolia on mammary breast cancer |
| 12/19/2007 | EP1649275A4 Dye solutions for use in methods to detect the prior evaporation of anhydrous ammonia and the production of illicit drugs |
| 12/19/2007 | EP1578366A4 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
| 12/19/2007 | EP1353694B1 Combinations of ezetimibe with aspirine for treating vascular conditions |
| 12/19/2007 | CN101090702A Topical composition |
| 12/19/2007 | CN100355755C Diazabicyclic central nervous system active agents |
| 12/19/2007 | CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity |
| 12/19/2007 | CA2820023A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 12/19/2007 | CA2549115A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 12/18/2007 | US7309814 Nucleic acid molecules encoding bacterial autoinducer inactivation protein as targets for engineering disease resistance |
| 12/18/2007 | US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 12/18/2007 | US7309504 Therapeutic agent or preventor of hepatitis, TNF- alpha inhibitor, health supplementary food |
| 12/18/2007 | CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer |
| 12/18/2007 | CA1341566C Immune response to tumors induced by anti-idiotype antibodies |
| 12/13/2007 | WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
| 12/13/2007 | WO2005039505A3 Compositions and methods for healthy pregnancy |
| 12/13/2007 | WO2005034852A3 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 12/13/2007 | US20070287949 Transdermal System for Sustained Delivery of Polypeptides |
| 12/13/2007 | US20070287688 Pharmaceutical Compositions for Topical Application |
| 12/13/2007 | US20070286916 Synbiotic Use |
| 12/12/2007 | EP1865319A1 Method of testing whether a tumor is susceptible to treatment with a ginkgo biloba extract or Ginkgolide B by testing whether the cancer is characterized by an over-expression of peripheral-type benzodiazepine receptor protein |
| 12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
| 12/12/2007 | EP1864975A2 Novel compounds |
| 12/12/2007 | EP1622579A4 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 12/12/2007 | CN101087631A Method and material for protecting skin |
| 12/12/2007 | CN101085853A 新的膜衣 The new film coating |
| 12/12/2007 | CN100354265C Pharmaceutical compounds |
| 12/12/2007 | CN100353946C Method of treating functional bowel disorders |
| 12/12/2007 | CN100353935C Pharmaceutical formulation contg. tolterodine and its use |
| 12/11/2007 | US7307154 DNA encoding a novel RG1 polypeptide |
| 12/11/2007 | US7307095 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307064 Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
| 12/11/2007 | US7306945 Fragment of alpha-synuclein is contacted with a drug; reduction in the rate or extent of aggregation fragment of alpha-synuclein relative to a control lacking the agent indicates the agent has the pharmacological activity |
| 12/11/2007 | US7306784 Complexing; drug delivery; in situ imaging |
| 12/06/2007 | WO2006086653A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/06/2007 | WO2005027854A3 T cell regulatory genes associated with immune disease |
| 12/06/2007 | WO2005023199A3 Socs-3 promoter methylation in cancer |